Successful Use of Levosimendan in a Patient with Peripartum Cardiomyopathy

    loading  Checking for direct PDF access through Ovid


This case represents the first reported use of levosimendan, a calcium-sensitizing drug with additional vasodilation properties, for treatment of a woman with peripartum cardiomyopathy. Levosimendan induced a steady decline of increased pulmonary capillary wedge pressure, followed by a definitive increase in cardiac stroke volume. The patient recovered from this serious episode of heart failure, and she ultimately regained left ventricular function.

Related Topics

    loading  Loading Related Articles